The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant ...

A range of current precision oncology clinical trials are reliant on customized, targeted NGS-panel assays in order to ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Along with the PBMs associated with Cigna and CVS, Optum allegedly price gouged on drugs like matinib, the generic version of the leukemia medicine Gleevec, the prostate cancer drug abiraterone ...

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...